Express Pharma
APRIL 8, 2025
A successful campaign drives engagement and shapes social norms through consistent digital communication – Bhavna Singh, Vice President Corporate Communications at Bharat Serums and Vaccines (BSV) “Communication is as effective as the content and the channels used. Digital Multi stakeholder communication rests heavily on engagement with the audience.
European Pharmaceutical Review
APRIL 22, 2025
New Phase III data has demonstrated the potential benefit of the monoclonal antibody obinutuzumab to treat lupus nephritis. This therapy is already approved for B cell malignancies. The REGENCY Phase III clinical trial evaluated 271 adults with active lupus nephritis, a severe complication of lupus that inhibits kidney function. Participants were randomised to receive either obinutuzumab plus mycophenolate mofetil and glucocorticoids as standard therapy, or a placebo plus standard therapy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
APRIL 27, 2025
Introduction In todays hyper-competitive healthcare space, building a Lead Generation Network in pharma is no longer optionalits essential. Much like a clinical trial needs carefully selected participants, pharma marketers must construct targeted networks to generate high-quality leads. But how does one translate an abstract marketing concept into a practical strategy that complies with strict regulatory frameworks while producing measurable outcomes?
STAT
APRIL 4, 2025
After Hurricane Ian, as Floridians returned home to sodden furniture and moldy piles of debris, many with asthma could feel their chests tightening. To figure out what was safe, some sent their concerns directly to the U.S. Centers for Disease Control and Prevention. But on Tuesday — days before floods ravaged Nashville, potentially prompting similar queries — the people who would normally answer such asthma questions stopped working.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
National Association of Boards of Pharmacy
APRIL 16, 2025
At NABP, we offer pharmacist examinations like the North American Pharmacist Licensure Examination (NAPLEX) and the Multistate Pharmacy Jurisprudence Examination (MPJE) to assess a pharmacists competency to practice while protecting the public health. In our last blog post, we discussed the development and the recent improvements that have been made to the MPJE and its purpose: to evaluate candidates understanding and application of federal and state-specific laws and regulations.
ID Stewardship
APRIL 16, 2025
In this article a current third year pharmacy student discusses pharmacy student study strategies to maximize learning in 2025 and beyond. Authored By:Fabian Quiroga, Pharm.D. Candidate 2026 Article posted 16 April 2025 No one really warns you about just how much content you will encounterin pharmacy school – until you are in it. Whether it is a single week, an entire module, or the full school year, the amount of material can feel overwhelming.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
European Pharmaceutical Review
APRIL 4, 2025
New findings from The Pistoia Alliance report major challenges to adoption of data-driven innovation and AI in life sciences. The research is based on a poll conducted at the organisations annual European conference. Resistance to change emerged as the biggest obstacle to innovation (51 percent). To overcome this, the Alliance urged the pharmaceutical industry to prioritise cultural and behavioural change in digital transformation efforts.
Pharma Marketing Network
APRIL 2, 2025
Introduction If the past few years have taught pharma marketers anything, it’s that agility, data, and digital-first thinking aren’t just buzzwordsthey’re survival tactics. Marketing in pharma has undergone a radical shift, propelled by digital transformation, patient-centric demands, and evolving regulatory landscapes. In 2025, the strategies that succeed are rooted in personalization, innovation, and real-time adaptability.
STAT
APRIL 23, 2025
The young people who wanted to quit e-cigarettes didn’t necessarily think they were addicted. But they did think nicotine cravings were a problem. When they enrolled in a Massachusetts General Hospital trial, they told researchers they couldn’t study in the library or work at their desks for long before getting the urge to vape. “They really didn’t like that loss of control,” said Eden Evins, director of the addiction center at Mass General.
Pharma Leaders
APRIL 3, 2025
The pharmaceutical sector, known for its stringent regulations demanding absolute transparency, traceability, and precision, is poised for a transformative shift. Even minor errors can have severe repercussions, driving leading companies to adopt digital tools, business process automation, and orchestration. Now, the integration of Generative AI (Gen AI) promises to further enhance efficiency, unlocking unprecedented levels of productivity and innovation.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
FDA Law Blog: Biosimilars
APRIL 8, 2025
By Kurt R. Karst The FDA Reduction-in-Force (Termination)or RIF(T)announced last week has resulted in countless stories in the press and on personal LinkedIn accounts from those RIFd. As the dust begins to settle and we all assess what this means for the future of FDA and the public health, generally, this blogger wanted to call out one particular division in the Office of Generic Drugs (OGD), funded by user fees under the Generic Drug User Fee Amendments (GDUFA), that was eradicated and what t
Express Pharma
APRIL 8, 2025
Novo Nordisk has released full results from the SOUL cardiovascular outcomes trial, a phase 3b study evaluating the impact of oral semaglutide on adults with type 2 diabetes who also have cardiovascular disease (CVD) and/or chronic kidney disease (CKD). The findings were presented during a late-breaking clinical session at the American College of Cardiology’s Annual Scientific Session and Expo in Chicago and were simultaneously published in the New England Journal of Medicine.
European Pharmaceutical Review
APRIL 25, 2025
The largest clinical trial investigating a treatment for bronchiectasis has demonstrated a statistically significant reduction in the occurrence of pulmonary exacerbations.Findings from the Phase III ASPEN study of brensocatib could provide future promise for patients, as there are currently no approved treatments for the chronic inflammatory pulmonary disease.
Pharma Marketing Network
APRIL 4, 2025
In the world of pharma marketing, the strategies that truly resonate are often those rooted in trust. Thats why referral marketing is gaining traction among pharmaceutical brands looking to increase engagement with both healthcare professionals and patients. Rather than relying solely on paid ads or direct promotion, referral marketing uses personal recommendations to generate awareness, interest, and ultimately, conversions.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
STAT
APRIL 25, 2025
Health and Human Services Secretary Robert F. Kennedy Jr. has railed against what he sees as a “revolving door” between workers at drug companies and the Food and Drug Administration. But his department’s actions now seem to be causing that door to spin ever faster. Scores of FDA employees are searching for an exit from an agency in turmoil, particularly staff members tasked with reviewing drug applications, according to interviews with former employees and industry re
The Pharmacist
APRIL 25, 2025
Almost five million Pharmacy First consultations were delivered in the first year of the service in England, official data has confirmed. The latest data from the NHS Business Services Authority (NHSBSA) shows that contractors in England submitted claims for 4,941,308 Pharmacy First consultations between February 2024 and January 2025. Of those, more than half (2,735,577) […] The post Almost five million Pharmacy First consultations delivered in first year appeared first on The Pharmacist.
RX Note
APRIL 19, 2025
Introduction While the selection of empirical antimicrobial therapy is highly subjective, depending on the patient's clinical condition (as reflected in antibiotic guidelines based on clinical indication) and ultimately guided by culture and sensitivity results, many pharmacists desire fundamental guidance on the typical applications of antimicrobials and those reserved for highly resistant bacteria.
Express Pharma
APRIL 25, 2025
ENTOD Pharmaceuticals has announced that it has received marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for a new ophthalmic formulation designed to slow the progression of myopia in children aged 6 to 12 years. This marks the first global regulatory approval for this specific treatment strength in paediatric eye care.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
European Pharmaceutical Review
APRIL 4, 2025
Analytical testing is an essential part of guaranteeing the quality, safety and effectiveness of pharmaceutical products. However, the process is not without its challenges and it requires a proactive approach if both compliance and efficiency are to be maintained. This is why it is essential to develop and validate analytical methods to support activities and functions such as process validation controls, stability tests and dissolution profiles.
Putting Patients First Blog
APRIL 8, 2025
NHC Submits Comments on FDA Draft Guidance for AI/ML-Enabled Medical Devices (PDF) April 7, 2025 Dockets Management Staff U.S. Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 RE: Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations [FDA-2024-D-4488] Submitted via regulations.gov To Whom It May Concern, The National Health Council (NHC) appreciates the opportunity to submit comments on the Food and D
STAT
APRIL 1, 2025
In 2024, total U.S. spending on prescription drugs was almost $800 billion. Although low-cost generic drugs filled 91% of all prescriptions, the 9% of prescriptions filled with a branded medicine accounted for 84% of drug spending. The monopolies on new drugs last so long, launch prices are so high, and price increases are so steep that they more than wipe out the savings Congress hoped to achieve by encouraging robust generic competition.
The Guardian - Pharmaceutical Industry
APRIL 22, 2025
Drugstore chain settles with DoJ over claims it dispensed millions of unlawful prescriptions for more than a decade Walgreens has agreed to pay up to $350m to settle claims by the US justice department that it illegally filled millions of prescriptions for opioids and other controlled substances. The countrys largest drugstore chain must pay the government $300m, plus an additional $50m if the corporation is sold, transferred or merged before 2032, according to the terms of the settlement reache
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
RX Note
APRIL 19, 2025
Introduction Most forms of systemic or disseminated fungal infections, including aspergillosis, candidiasis, cryptococcosis, and histoplasmosis, typically require systemic antifungal treatment. Azole Antifungals Triazole antifungal drugs have a role in the prevention and systemic treatment of fungal infections, but the coverage and indications vary widely.
Express Pharma
APRIL 4, 2025
A recent study reveals that a single dose of Bavarian Nordics Jynneos vaccine demonstrated 58 per cent overall effectiveness in preventing mpox infection. Among the participants without HIV, effectiveness rose to 84 per cent, while those with HIV showed only 35 per cent effectiveness. These findings underscore the critical need for enhanced mpox prevention strategies for vulnerable, high-risk populations, particularly those with HIV, says GlobalData.
Pharma Marketing Network
APRIL 22, 2025
Introduction Pharma brands are rethinking their digital engagement strategies in 2025. With regulatory scrutiny evolving and audience expectations shifting, social media marketing plans have become a central focus for companies looking to maintain trust while expanding reach. Social platforms are no longer just optional toolsthey’re vital channels for HCP and patient engagement.
Pharmaceutical Business Review
APRIL 24, 2025
This recommendation facilitates treating the activated phosphoinositide 3-kinase delta (PI3K) syndrome (APDS) in patients aged 12 years and above. The oral therapy is now accessible and funded in England through the Innovative Medicines Fund and is expected to be funded in Wales within the coming three months. The NICE endorsement is supported by the comprehensive data, including a Phase III clinical trial of leniolisib, which showed significant improvements in immune deficiency and dysregulatio
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
STAT
APRIL 23, 2025
Amid ongoing battles over alternate supplies of blockbuster weight loss drugs, Eli Lilly filed new lawsuits against four telehealth firms and their affiliates, but is using a new line of attack — the drugmaker accused two of the companies of engaging in the corporate practice of medicine. To date, Lilly and its rival, Novo Nordisk, have filed dozens of suits against numerous companies involved in compounding versions of semaglutide and tirzepatide, the obesity and diabetes drugs known as
The Pharmacist
APRIL 22, 2025
There has been a fall in vaping and disposable e-cigarette use following the UK Governments announcement of regulations, a study has found. The research led by a team at University College London (UCL) and published inAddiction used data from the Smoking Toolkit Study, a monthly household survey of adults in England, Wales and Scotland. […] The post Vaping trends stall following regulation announcement appeared first on The Pharmacist.
RX Note
APRIL 18, 2025
Introduction The rapid advancement of artificial intelligence necessitates a critical re-evaluation and fundamental reform of pharmacy education to prepare future practitioners for a dramatically changing landscape. With the increasing prevalence of artificial intelligence in academic assignments and daily life, we are inclined to seek quick answers by simply asking, rather than engaging in thoughtful problem-solving.
Express Pharma
APRIL 14, 2025
At the recently held 2025 American Academy of Neurology (AAN) meeting, Remegen presented positive Phase III results for telitacicept in patients with AChR+ or MuSK+ generalised myasthenia gravis (gMG). The B cell-targeting therapy demonstrated a favorable efficacy and safety profile over 24 weeks, showing clinically meaningful improvement. These findings position telitacicept as a potential challenger to the existing disease-modifying therapies (DMTs), says GlobalData.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Expert insights. Personalized for you.
101 
Let's personalize your content